Provided by Tiger Trade Technology Pte. Ltd.

Tenaris SA

52.66
-0.0200-0.04%
Post-market: 52.660.00000.00%19:30 EDT
Volume:867.82K
Turnover:45.60M
Market Cap:26.59B
PE:14.10
High:53.29
Open:52.80
Low:52.07
Close:52.68
52wk High:64.60
52wk Low:33.65
Shares:505.00M
Float Shares:159.00M
Volume Ratio:0.45
T/O Rate:0.55%
Dividend:1.78
Dividend Rate:3.38%
EPS(TTM):3.73
EPS(LYR):3.66
ROE:11.58%
ROA:6.79%
PB:1.57
PE(LYR):14.39

Loading ...

Morgan Stanley Raises Price Target on Tenaris to $53 From $50, Keeps Underweight Rating

MT Newswires Live
·
May 14

TS Financial's Revenue Rises 16% in April

MT Newswires Live
·
May 14

Aware Announces Successful Independent Evaluation of Intelligent Liveness Aligned with CEN/TS 18099

GlobeNewswire
·
May 13

TS Tech’s FY2026 Profit Falls as Margins Tighten, But Dividends and FY2027 Outlook Hold Steady

TIPRANKS
·
May 13

TS Tech Co Sees FY Net Y8.00B

Dow Jones
·
May 13

Tenaris to acquire Artrom Steel Tubes plant in Romania

TIPRANKS
·
May 10

Tenaris Agrees to Buy Artrom Steel Tubes for $101M

Dow Jones
·
May 09

Tenaris Is Maintained at Overweight by Barclays

Dow Jones
·
May 09

Stock Track | Tenaris Plunges 6.04% in Pre-market as Cautious Q2 Outlook Overshadows Strong Q1 Earnings Beat

Stock Track
·
May 07

Tenaris Names Gabriel Podskubka Chief Executive

MT Newswires Live
·
May 07

Stock Track | Tenaris Plunges 5.43% on Cautious Q2 Outlook Despite Strong Q1 Earnings Beat

Stock Track
·
May 07

Tenaris names Gabriel Podskubka CEO

TIPRANKS
·
May 07

Press Release: Tenaris Announces CEO succession

Dow Jones
·
May 07

Tenaris Q1 EPS $1.07 Beats $0.48 Estimate, Sales $3.100B Beat $2.985B Estimate.

Benzinga Earnings
·
May 07

Press Release: Tenaris Announces 2026 First Quarter Results

Dow Jones
·
May 07

Tenaris SA expected to post earnings of 88 cents a share - Earnings Preview

Reuters
·
May 05

Earning Preview: Tenaris SA this quarter’s revenue is expected to increase by 2.45%, and institutional views are bullish

Earnings Agent
·
Apr 29

Teva to Acquire Emalex Biosciences, Adding NDA-Ready, First-in-Class Therapy to Neuroscience Pipeline and Accelerating Teva’s Pivot to Growth Strategy

GlobeNewswire
·
Apr 29

TS Financial-Owned Shin Kong Venture to Liquidate Unit

MT Newswires Live
·
Apr 24

Tenaris Is Maintained at Overweight by Barclays

Dow Jones
·
Apr 20